PLRX
Asset Logo

Pliant Therapeutics Inc

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-7.61%
Annual Growth

4 years average annual growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Pliant Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapies for the treatment of fibrosis and related diseases. Its lead product candidate, bexotegrast (PLN-74809), is an oral, small molecule, dual selective inhibitor of αvß6 and αvß1 integrins that is in development in the lead indications for the treatment of idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC). The Company has initiated BEACON-IPF, a Phase 2b trial of bexotegrast in IPF. It has also developed PLN-1474, a small molecule, selective inhibitor of αvß1 integrin for the treatment of non-alcoholic steatohepatitis (NASH) with liver fibrosis. It has initiated a Phase 1 study for its third clinical program, PLN-101095, a small molecule, dual-selective inhibitor of αvß8 and αvß1 integrins, that is being developed for the treatment of solid tumors. The Company has a preclinical program, PLN-101325, targeting muscular dystrophies.

📈 Performance

Price History*

-33.67%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$14.52

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in PLRX

1

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

20 weeks

💵 Average investment amount

$2,000

Last time a customer invested in PLRX

312 days
PLRX investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100%

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

100%
🙋 Legal gender of investors

Female

Male

100%

Pearlers who invest in PLRX also invest in...

C4 Therapeutics, Inc

CCCC

📊 Share price

$5.61 USD
Find Out More

🙌 Performance (5Yr p.a)

-10.98%

📊 Share price

$3.87 USD

🙌 Performance (5Yr p.a)

46.71%

📊 Share price

$50.30 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

0.34%

📊 Share price

$1.82 USD

🙌 Performance (5Yr p.a)

3.88%

📊 Share price

$99.27 USD

Want more shares? Try these...

📊 Share price

$1.17 USD

🙌 Performance (5Yr p.a)

20.98%

📊 Share price

$126.00 USD

📈 HIGH PRICE GROWTH

Compare
Add to watchlist